Revenue by GeographySep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21Sep '21

United States Revenue

63,611

59,746

International Revenue

419

434

Other Revenue by Geography

-21

-21

Total Revenue by Geography

64,009

60,159

RevenueSep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21Sep '21

Pharmaceutical and Specialty Solutions Revenue

59,205

55,372

Global Medical Products and Distribution Revenue

3,184

3,199

Other Segment Revenue

1,641

1,609

Other Revenue

-21

-21

Total Revenue

64,009

60,159

RevenueSep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21Sep '21

Pharmaceutical Distribution and Specialty Solutions Revenue

—

—

Nuclear and Precision Health Solutions Revenue

—

—

Pharmaceutical Segment Revenue

—

—

Medical Distribution and Products Revenue

—

—

Cardinal Health at-Home Solutions Revenue

—

—

Medical Segment Revenue

—

—

Other Revenue

—

—

Total Revenue

64,009

60,159

EBITSep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21Sep '21

Pharmaceutical and Specialty Solutions Segment Profit

667

535

Global Medical Products and Distribution Segment Profit

46

70

Other Segment Segment Profit

166

160

Corporate Profit

-211

-337

Other EBIT

—

—

Total EBIT

668

428

EBITSep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21Sep '21

Corporate Profit

-211

-337

Pharmaceutical Segment Profit

—

—

Medical Segment Profit

—

—

Other EBIT

879

765

Total EBIT

668

428